Related references
Note: Only part of the references are listed.Epilepsy in the cancer patient
Odysseas Kargiotis et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
Stuart A. Grossman et al.
CLINICAL CANCER RESEARCH (2011)
Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
Joerg Felsberg et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era
Anthony J. Paravati et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
O6-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation
Simone Kreth et al.
PLOS ONE (2011)
Patterns of Care and Survival in a Retrospective Analysis of 1059 Patients With Glioblastoma Multiforme Treated Between 2002 and 2007: A Multicenter Study by the Central Nervous System Study Group of Airo (Italian Association of Radiation Oncology)
Silvia Scoccianti et al.
NEUROSURGERY (2010)
Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy
Chul-Kee Park et al.
BMC CANCER (2009)
Anaplastic Gliomas
Lisa M. DeAngelis
JOURNAL OF CLINICAL ONCOLOGY (2009)
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Independent association of extent of resection with survival in patients with malignant brain astrocytoma
Matthew J. McGirt et al.
JOURNAL OF NEUROSURGERY (2009)
Drug interactions between chemotherapeutic regimens and antiepileptics
Kevin Yi-Lwern et al.
CLINICAL THERAPEUTICS (2008)
Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: Results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882)
Jerzy Hildebrand et al.
EUROPEAN JOURNAL OF CANCER (2008)
Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors
Stephanie E. Combs et al.
RADIOTHERAPY AND ONCOLOGY (2008)
Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach
David Capper et al.
ACTA NEUROPATHOLOGICA (2008)
Anaplastic astrocytoma in adults
Roger Stupp et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Prognostic factors for anaplastic astrocytomas
Alessia Compostella et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma?
Malika L. Siker et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma
Alba A. Brandes et al.
NEURO-ONCOLOGY (2006)
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers
Stefano Maria Magrini et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas
M Brell et al.
CLINICAL CANCER RESEARCH (2005)
Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide
M Brada et al.
ANNALS OF ONCOLOGY (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma - A North American Brain Tumor Consortium Trial
SM Chang et al.
CANCER (2004)
Prognostic Pathologic implication of clinical, radiologic, and features in patients with anaplastic gliomas
A Tortosa et al.
CANCER (2003)
Randomized trial of porcarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: A medical research council trial
D Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
